Please assess the completion status of the following clinical trial:

Trial Title: A Study of Controlled-Release Carvedilol Compared to Immediate-Release Carvedilol in Patients With Primary Hypertension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Have a diagnosis of mild or moderate primary hypertension~* Be able to tolerate a 2 week washout phase followed by a 2 week Placebo run- in phase~* Be minimum 18 years of age~Exclusion Criteria:~* Be intolerant to alfa- or beta-blockers~* Have secondary causes of hypertension~* Be taking more than two antihypertensive medications

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Egalet carvedilol
- 2 (Type: ACTIVE_COMPARATOR): Coreg

Based on this trial design, predict the completion outcome and termination type (if applicable).